| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |